Palisade Bio Inc (PALI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2007 | 12-2006 | 09-2006 | 06-2006 | 03-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -949 | -3,148 | -1,845 | -1,634 | -475 |
| Depreciation Amortization | 13 | 52 | 39 | 27 | 13 |
| Accounts receivable | -79 | N/A | N/A | N/A | N/A |
| Other Working Capital | 59 | -599 | -677 | -517 | -407 |
| Other Operating Activity | 155 | 360 | 61 | 421 | 0 |
| Operating Cash Flow | $-802 | $-3,335 | $-2,422 | $-1,703 | $-870 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -4 | -54 | -45 | -49 | -13 |
| Purchase Sale Intangibles | -4 | -6 | N/A | N/A | N/A |
| Other Investing Activity | -4 | -6 | 0 | 0 | 0 |
| Investing Cash Flow | $-8 | $-59 | $-45 | $-49 | $-13 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -2 | -125 | -123 | -121 | -120 |
| Common Stock Issued | 5,643 | 4,800 | 4,550 | 4,550 | 4,550 |
| Financing Cash Flow | $5,641 | $4,675 | $4,427 | $4,429 | $4,430 |
| Beginning Cash Position | 1,807 | 526 | 526 | 526 | 526 |
| End Cash Position | 6,638 | 1,807 | 2,486 | 3,203 | 4,075 |
| Net Cash Flow | $4,831 | $1,281 | $1,960 | $2,676 | $3,548 |
| Free Cash Flow | |||||
| Operating Cash Flow | -802 | -3,335 | -2,422 | -1,703 | -870 |
| Capital Expenditure | -4 | -54 | -45 | -49 | -13 |
| Free Cash Flow | -806 | -3,389 | -2,467 | -1,752 | -882 |